Breakthrough T1D NorCal May 2022 Newsletter
Vertex Provides an Update on the VX-880 Clinical Trial VX-880 is the name of the Vertex therapy undergoing clinical testing.…
Breakthrough T1D NorCal April 2022 Newsletter
National Volunteer Appreciation Week: April 17-23, 2022 During National Volunteer Week (April 17-23, 2022), Breakthrough T1D will celebrate the passion…
Breakthrough T1D NorCal March 2022 Newsletter
Breakthrough T1D Joins Civica to Make Low-Cost Insulin Available to All Americans In conjunction with leading partners in diabetes, advocacy,…
The 2020 Annual Meeting & Research Discussion
Thank you to everyone who attended the 2020 Annual Meeting & Research Discussion. We hope you agree that this year’s…
Join us on Twitch.TV
We’re offering informative and relevant content to support people living with type 1 diabetes (T1D), as well as some lighter…
Research Update: T1D Devices
Devices are innovative tools designed, engineered and built to help type 1 diabetics manage blood glucose. Although device development has…
New Year – New Volunteer Opportunity!
Are you interested in learning about the latest advancements in type 1 diabetes (T1D) research? Do you wonder how dollars…
Participate in a T1D Clinical Trial in Northern California
Thank you for visiting this blog! Please visit our new Clinical Trials landing page for information and details of trials…
Greater Bay Area Chapter to Honor Co-Directors of the Breakthrough T1D Northern California Center of Excellence: Dr. Matthias Hebrock, Ph.D, UCSF, & Seung Kim, M.D., Ph.D., Stanford
On Saturday, May 16, 2020, the Breakthrough T1D Greater Bay Area Chapter will host the 22nd Annual Hope Gala, bringing prominent…
Recent Advancements in T1D Research: Genetic Markers, Prick –Free Glucose Monitoring, Automatic Insulin Dosage Systems and Regeneration of Beta Cells
At Breakthrough T1D, our most essential work takes place in the exciting world of Type 1 Diabetes research. Our donors…
